Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Ottawa Marriott Hotel

Oct 27, 2015 8:30 AM - Oct 28, 2015 3:00 PM

100 Kent Street , Ottawa, ON K1P5R7 , CANADA

DIA Annual Canadian Meeting 2015

Overview

Tutorials:  October 26*
Tutorial #1- Plain Language Labeling: Implementing Health Canada's Guidance for Industry
Tutorial #2- Strategies for Efficient Submission Preparation
*Tutorials require registration and are an additional fee


Meeting:  October 27-28


A New Era in Regulatory Affairs - Building Capabilities to Support Innovation, Transparency, Quality and Safety of Health Products in Canada

As the Canadian health care system continues to evolve, the need for transparency is playing an important role in the development and management of new and existing medicines and devices.  Numerous stakeholders are working to build regulatory capabilities that will help to promote innovation and to maintain high standards of quality and safety of important therapies and medicines in Canada.

The DIA Annual Canadian Meeting 2015 will bring together key thought leaders and experts, representing various stakeholders, to explore what this new era of regulatory affairs means to the Canadian health care and biopharmaceutical industries.

This year’s meeting will feature plenary sessions, multi-track breakout sessions, networking opportunities, tutorials and tabletop exhibiting opportunities.

Featured

Want to learn more about DIA Annual Canadian Meeting 2015? You've come to the right site!

Continuing-Education

Exhibits

Who should attend?

Professionals involved in:

  • Regulatory Affairs
  • Policy/Pharmacoeconomics
  • Clinical Development
  • Drug Safety/Pharmacovigilance
  • Patient Safety
  • Medical Communications
  • Quality Operations

Learning objectives

At the conclusion of this meeting, participants should be able to:

  • Describe the current and evolving regulatory environment in Canada
  • Recognize the challenges faced by various Canadian stakeholders in the development, regulation, and harmonization of, accessing the state-of-the-art medicines and devices within a global context
  • Discuss new technologies and efficiencies to support drug and device development
  • Describe quality measures to support improved inspections and manufacturing practices

Short Course or Primer

To keep you at the forefront.

Oct 26, 2015

Tutorial #1 - Plain Language Labeling:

Implementing Health Canada's Guidance for Industry

Oct 26, 2015

Tutorial #2 - Strategies for Efficient Submission Preparation:

Program Committee

  • Karen  Feltmate
    Karen Feltmate President
    Redstone Health Group, Inc., Canada
  • Matthew  Ryan
    Matthew Ryan Senior Policy Analyst; Policy, Planning and International Affairs Directorate
    Health Canada, Canada
  • Marilena  Bassi, MA
    Marilena Bassi, MA Senior Executive Director, Therapeutic Products Directorate
    Health Canada, Canada
  • Rocelyn  DelCarmen
    Rocelyn DelCarmen Director, Regulatory Affairs and Quality Assurance
    Astrazeneca Canada Inc., Canada
  • Maggie  Graham
    Maggie Graham Senior Policy Analyst, Natural and Non-Prescription Health Products Directorate
    Health Canada, Canada
  • Vratislav  Hadrava, MD, PhD
    Vratislav Hadrava, MD, PhD Vice President and Medical Director, Global Innovative Products
    Pfizer Canada, Inc., Canada
  • Ljubica  Ivanisevic, PhD
    Ljubica Ivanisevic, PhD Scientific Evaluator
    Health Canada, Canada
  • Chanez Narimene  Kebache, MBA
    Chanez Narimene Kebache, MBA Director, Global Product Safety & Pharmacovigilance
    Canopy Growth Corporation, Canada
  • Marc  Poitras, PhD, MBA
    Marc Poitras, PhD, MBA Scientific Manager, Marketed Pharmaceuticals and Medical Devices Bureau
    Health Canada, Canada

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.